Actively Recruiting
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
Led by Academisch Ziekenhuis Maastricht · Updated on 2024-07-23
7000
Participants Needed
1
Research Sites
1095 weeks
Total Duration
On this page
Sponsors
A
Academisch Ziekenhuis Maastricht
Lead Sponsor
N
Novartis
Collaborating Sponsor
AI-Summary
What this Trial Is About
The Southeast Netherlands Advanced Breast Cancer (SONABRE) Registry is a real life multi-center study. The registry aims to include all patients diagnosed with advanced breast cancer as of 2007 in 11 hospitals in the Netherlands. Data on patient, tumor and treatment characteristics are collected retrospectively from electronic medical files by trained registry clerks.
CONDITIONS
Official Title
Southeast Netherlands Advanced Metastatic Breast Cancer Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with de novo or recurrent advanced breast cancer since 2007
- Diagnosed with or treated for advanced breast cancer in one of the participating hospitals
- Participating hospitals and inclusion periods: Maastricht UMC+ (2007-2025), Zuyderland hospitals Sittard/Heerlen (2007-2025), Amphia Hospital Breda (2013-2025), Catharina Hospital Eindhoven (2007-2025), Elkerliek Hospital Helmond (2010-2025), Maxima Medical Center Veldhoven/Eindhoven (2007-2025), Jeroen Bosch Hospital Den Bosch (2013-2025), Laurentius Hospital Roermond (2007-2025), St. Annaziekenhuis Geldrop (2007-2025), St. Elisabeth Hospital Tilburg (2007-2009), St. Jans Gasthuis Weert (2007-2025), VieCuri Medical Center Venlo/Venray (2013-2025), all in the Netherlands
- Hospitals (and periods) were eligible for inclusion if distant registration from Maastricht UMC+ was possible
- The inclusion period may be prolonged after 2025
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Multiple hospitals in the Netherlands (see Eligibility)
Maastricht, Netherlands
Actively Recruiting
Research Team
V
Vivianne CG Tjan-Heijnen, MD, PhD
CONTACT
S
Sandra ME Geurts, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here